Jukka Westermarck profile picture

Jukka Westermarck

Has open position

Professor

University of Turku
Country flag
Finland

Research Interests

Explore related searches

Contact this professor

LinkedIn
ORCID
Google Scholar
Academic Page

Positions (2)

Publisher
source

Jukka Westermarck

University Name
.

University of Turku

Post-doctoral position in drug development at Turku Finland

A post-doctoral position in drug development is available in the laboratory of Professor Jukka Westermarck at the Turku Bioscience Centre, University of Turku, Finland. The Turku Bioscience Centre is a leading research facility with distinguished research groups and excellent core services, situated within a vibrant biomedical campus that hosts over 100 research groups, including a strong cancer research community. The working language is English, and the University of Turku offers comprehensive welcome services for newcomers. The research project focuses on evaluating the therapeutic potential of targeting the PP2A inhibitor protein CIP2A. Recent advancements have opened exciting opportunities for direct targeting of CIP2A, and the group is seeking a highly motivated senior postdoctoral fellow with solid experience in structural biology and small molecule targeting to explore these novel findings. Obligatory candidate requirements include a PhD with postdoctoral experience, hands-on expertise in protein chemistry and interaction technologies, a first author publication related to structural biology in a high-quality journal, and a publication on phosphoproteome signaling and/or phosphatases. Strong team-working and communication skills are essential. Preferred technical competencies include experience with cancer cell culture methods, small molecule targeting, and a solid understanding of CIP2A/PP2A biology. Eligibility requirements are defined in the University of Turku's regulations. The University of Turku values collegiality, equality, diversity, and inclusivity, and encourages applicants from diverse backgrounds. The position offers responsible and interesting tasks, opportunities for professional development, flexible working hours, comprehensive occupational health care, and access to CampusSport’s services at a personnel price. The university supports work-life balance with flexible hours and remote work options, and fosters an inspiring and supportive work community. The European Commission has awarded the University of Turku the HR Excellence in Research quality label, reflecting its commitment to continuous development of researcher positions and working conditions. The position is available starting from August 10, 2026, or later by agreement, with funding secured until April 30, 2030. The salary is determined by the university salary system and will be on average 3700–4100 euros/month, depending on experience and skills. A six-month trial period applies. Applicants should submit their application through the online recruitment system, including a one-page application letter, CV, complete list of publications, copy of PhD certificate (with official English translation if not in Finnish or English), and contact details of three referees. Applications are assessed on a rolling basis, and shortlisted candidates may be invited to interview before the closing date. For inquiries, contact Professor Jukka Westermarck ([email protected]) or HR Specialist Paula Luoma ([email protected]). Turku Bioscience Centre is jointly hosted by University of Turku and Åbo Akademi University, aiming to provide comprehensive research services and facilitate academic-industry collaborations. The University of Turku is an international academic community of 25,000 students and staff, committed to multidisciplinary research, education, and collaboration for a sustainable future. Application deadline: May 22, 2026. Location: Tykistökatu 6, Turku, Finland.

4 months ago

Publisher
source

Jukka Westermarck

University Name
.

University of Turku

Post-doctoral Position in Drug Development and CIP2A Targeting at Turku Bioscience Centre

Post-doctoral position in drug development is available at the Westermarck laboratory, Turku Bioscience Centre, University of Turku, Finland. The project focuses on evaluating the therapeutic potential of targeting CIP2A, a PP2A inhibitor protein with a central pathogenic role in certain incurable cancer types and other diseases. The group highlights recent advances suggesting exciting opportunities for direct targeting of CIP2A. The work is embedded in a strong cancer research environment with excellent core facilities and a large biomedical campus. Applicants should have a PhD or be close to completion, with solid hands-on experience in protein chemistry and protein interaction technologies. A first-author publication directly related to the field is required. Preferred experience includes small molecule development, high-throughput screening, structural biology methods, and computational structural analysis. Strong teamwork and communication skills are also valued. The position is fixed-term and starts on 1 January 2027 or as agreed, continuing until 31 December 2029. The working language is English. Salary follows the University of Turku salary system; a Postdoctoral Researcher typically earns about EUR 3,700–4,000 gross per month, while candidates without an officially completed PhD may initially be appointed as Project Researcher for one year at about EUR 3,200–3,300 gross per month. To apply, submit your application through the online recruitment system in English. Include a one-page application letter explaining how your profile matches the requirements, your CV, complete publication list, and names/contact details of three referees. If you have questions before applying, contact Professor Jukka Westermarck by email.

New Today

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI